Acorah Software Products - Accounts Production 15.0.600 false true 31 December 2022 1 January 2022 false 1 January 2023 31 December 2023 31 December 2023 08476556 Rohan Agarwal Testbusters UK Holdings Ltd Testbusters SRL false iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08476556 2022-12-31 08476556 2023-12-31 08476556 2023-01-01 2023-12-31 08476556 frs-core:CurrentFinancialInstruments 2023-12-31 08476556 frs-core:Non-currentFinancialInstruments 2023-12-31 08476556 frs-core:ComputerEquipment 2023-12-31 08476556 frs-core:ComputerEquipment 2023-01-01 2023-12-31 08476556 frs-core:ComputerEquipment 2022-12-31 08476556 frs-core:PlantMachinery 2023-12-31 08476556 frs-core:PlantMachinery 2023-01-01 2023-12-31 08476556 frs-core:PlantMachinery 2022-12-31 08476556 frs-core:ShareCapital 2023-12-31 08476556 frs-core:RetainedEarningsAccumulatedLosses 2023-12-31 08476556 frs-bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 08476556 frs-bus:FilletedAccounts 2023-01-01 2023-12-31 08476556 frs-bus:SmallEntities 2023-01-01 2023-12-31 08476556 frs-bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 08476556 frs-bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 08476556 frs-bus:OrdinaryShareClass1 2023-01-01 2023-12-31 08476556 frs-bus:OrdinaryShareClass1 2023-12-31 08476556 1 2023-01-01 2023-12-31 08476556 frs-bus:Director1 2023-01-01 2023-12-31 08476556 frs-bus:Director2 2023-01-01 2023-12-31 08476556 frs-countries:EnglandWales 2023-01-01 2023-12-31 08476556 2021-12-31 08476556 2022-12-31 08476556 2022-01-01 2022-12-31 08476556 frs-core:CurrentFinancialInstruments 2022-12-31 08476556 frs-core:Non-currentFinancialInstruments 2022-12-31 08476556 frs-core:ShareCapital 2022-12-31 08476556 frs-core:RetainedEarningsAccumulatedLosses 2022-12-31 08476556 frs-bus:OrdinaryShareClass1 2022-01-01 2022-12-31
Registered number: 08476556
RAR Medical Services Limited
Unaudited Financial Statements
For The Year Ended 31 December 2023
Sterling Accounting Solutions Ltd
Chartered Accountants
SAS House
Chipperfield Road
Kings Langley
Hertfordshire
WD4 9JB
Unaudited Financial Statements
Contents
Page
Company Information 1
Accountants' Report 2
Statement of Financial Position 3—4
Notes to the Financial Statements 5—8
Page 1
Company Information
Directors Rohan Agarwal
Testbusters UK Holdings Ltd
Company Number 08476556
Registered Office SAS House
Chipperfield Road
Kings Langley
Hertfordshire
WD4 9JB
Accountants Sterling Accounting Solutions Ltd
Chartered Accountants
SAS House
Chipperfield Road
Kings Langley
Hertfordshire
WD4 9JB
Page 1
Page 2
Accountants' Report
Chartered Accountants' report to the directors on the preparation of the unaudited statutory accounts of RAR Medical Services Limited For The Year Ended 31 December 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of RAR Medical Services Limited for the year ended 31 December 2023 which comprise the Income Statement, the Statement of Financial Position and the related notes from the company's accounting records and from information and explanations you have given to us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/en/membership/regulations-standards-and-guidance.
This report is made solely to the directors of RAR Medical Services Limited , as a body, in accordance with the terms of our engagement letter dated . Our work has been undertaken solely to prepare for your approval the accounts of RAR Medical Services Limited and state those matters that we have agreed to state to the directors of RAR Medical Services Limited , as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than RAR Medical Services Limited and its directors, as a body, for our work or for this report.
It is your duty to ensure that RAR Medical Services Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit or loss of RAR Medical Services Limited . You consider that RAR Medical Services Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit of the accounts of RAR Medical Services Limited . For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the financial statements.
Signed
Sterling Accounting Solutions Ltd
16/09/2024
Sterling Accounting Solutions Ltd
Chartered Accountants
SAS House
Chipperfield Road
Kings Langley
Hertfordshire
WD4 9JB
Page 2
Page 3
Statement of Financial Position
Registered number: 08476556
2023 2022
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 344 430
344 430
CURRENT ASSETS
Debtors 5 367 8,573
Cash at bank and in hand 488,691 368,158
489,058 376,731
Creditors: Amounts Falling Due Within One Year 6 (49,284 ) (54,754 )
NET CURRENT ASSETS (LIABILITIES) 439,774 321,977
TOTAL ASSETS LESS CURRENT LIABILITIES 440,118 322,407
Creditors: Amounts Falling Due After More Than One Year 7 (14,167 ) (24,167 )
NET ASSETS 425,951 298,240
CAPITAL AND RESERVES
Called up share capital 8 100 100
Income Statement 425,851 298,140
SHAREHOLDERS' FUNDS 425,951 298,240
Page 3
Page 4
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Income Statement.
On behalf of the board
Rohan Agarwal
Director
16/09/2024
The notes on pages 5 to 8 form part of these financial statements.
Page 4
Page 5
Notes to the Financial Statements
1. General Information
RAR Medical Services Limited is a private company, limited by shares, incorporated in England & Wales, registered number 08476556 . The registered office is SAS House, Chipperfield Road, Kings Langley, Hertfordshire, WD4 9JB.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
These financial statements have been prepared in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland" ("FRS 102") and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 20% reducing balance
Computer Equipment 20% reducing balance
Page 5
Page 6
2.4. Financial Instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price and are subsequently measured as follows: Debt instruments are subsequently measured at amortised cost and commitments to receive a loan and to make a loan to another entity are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment.
All other financial instruments, including derivatives, are initially recognised at fair value, which is normally the transaction price and are subsequently measured at fair value, with any changes recognised in profit or loss.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.
All equity instruments regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics.
Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
2.5. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
Page 6
Page 7
3. Average Number of Employees
Average number of employees, including directors, during the year was: 3 (2022: 3)
3 3
4. Tangible Assets
Plant & Machinery Computer Equipment Total
£ £ £
Cost
As at 1 January 2023 1,069 887 1,956
As at 31 December 2023 1,069 887 1,956
Depreciation
As at 1 January 2023 834 692 1,526
Provided during the period 47 39 86
As at 31 December 2023 881 731 1,612
Net Book Value
As at 31 December 2023 188 156 344
As at 1 January 2023 235 195 430
5. Debtors
2023 2022
£ £
Due within one year
Other debtors 367 8,573
367 8,573
6. Creditors: Amounts Falling Due Within One Year
2023 2022
£ £
Bank loans and overdrafts 10,000 10,000
Corporation tax 39,284 22,140
Other creditors - 22,614
49,284 54,754
7. Creditors: Amounts Falling Due After More Than One Year
2023 2022
£ £
Bank loans 14,167 24,167
14,167 24,167
Page 7
Page 8
8. Share Capital
2023 2022
Allotted, called up and fully paid £ £
100 Ordinary Shares of £ 1.00 each 100 100
9. Dividends
2023 2022
£ £
On equity shares:
Final dividend paid - 10,000
- 10,000
10. Related Party Transactions
At the year end £367 (2022: £818) was owed from Medox Tutors Limited, a company in which Rohan Agarwal is a director. The balance is included within other debtors.
At the year end £Nil (2022: £7,755) was owed from 6Med Limited, a company in which Rohan Agarwal is a director.
11. Parent Undertaking and Controlling Party
The company's immediate and parent undertaking is Testbusters UK Holdings Ltd . Testbusters UK Holdings Ltd was incorporated in England and Wales. 
The ultimate controlling party is Testbusters SRL who controls 100% of the shares of Testbusters UK Holdings Ltd .
Page 8